Latest News

Back to resources

Displaying 57 - 64 of 68

R&D
Four Massachusetts-based Cell and Gene Therapy start-ups that are taking 2022 by storm
The east coast of America is seeing a boom in the number of cell and gene therapy (CGT) star...

By Jacob Perrett September 6th, 2022
Commercial
An insight into the challenges of cell and gene therapy commercialisation
Reaching the market with cell and gene therapies (CGTs) is no easy task. Despite there being...

By SEC Newsroom August 23rd, 2022
Clinical & Medical
Four biotech innovators transforming mental health care
A mental health crisis has sparked innovation from major names within the biotechnology indu...

By SEC Newsroom August 22nd, 2022
Clinical & Medical
The rise of virtual clinical trials and why they are here to stay
The COVID-19 pandemic has drastically derailed onsite clinical trials worldwide, leaving las...

By SEC Newsroom June 28th, 2022
Data & Tech
The cost of poor data quality in drug development
Data is integral to the development of new drugs. As the linchpin around which analysis, sub...

By SEC Newsroom May 17th, 2022
Candidates
90 days to shine: How to make an impact in your new role
Starting a new job can be nerve-wracking, but the first 90 days will really shape your journ...

By SEC Newsroom April 26th, 2022
Employers
How do I effectively onboard a remote hire?
Workforces are set to embrace working from home in one way or another, even when the pandemi...

By SEC Newsroom March 15th, 2022
Candidates
Starting your new job remotely? Here are 6 things to consider
Starting a new role is daunting, especially in a remote-first world. Your onboarding period ...

By SEC Newsroom February 1st, 2022